Is NCT07864168 recruiting in Chula Vista, CA?

Yes, NCT07864168 is currently recruiting participants at its Chula Vista, CA location. This type 1 diabetes clinical trial is actively enrolling qualified participants.

How do I join the type 1 diabetes clinical trial in Chula Vista?

To join this clinical trial in Chula Vista, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Chula Vista clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Type 1 Diabetes Clinical Trial in Chula Vista, CA

Who Can Participate

Inclusion Criteria

Age 2-80 years at time of screening.

Has a clinical diagnosis of diabetes as stipulated according to the following age group:

Age 2-10 years: Has a clinical diagnosis of T1D or T2D as determined via medical record/ source documentation by an individual qualified to make a medical diagnosis.

Age 11-80 years: Has a clinical diagnosis of T1D or T2D for 6 months or more, as determined via medical record or source documentation by an individual qualified to make a medical diagnosis.

Subject or parent(s)/ guardian(s)/ caregiver(s) is/are literate and able to read the language offered in the study materials.

Is willing to provide informed consent/assent for participation.

If participating in BGA FST, has adequate venous access as assessed by investigator or appropriate staff.

Is willing to perform fingerstick blood glucose measurements as needed.

Is willing to wear the study devices continuously throughout the study.

Subject or parent(s)/guardian(s)/caregiver(s) is/are willing to complete the requirements for diary data entry, as applicable.

If participating in glycemic challenges, has met the following conditions:

Been using insulin for at least 3 months

A relatively stable insulin-to-carbohydrate ratio(s) and insulin sensitivity factor(s) for at least one month per investigator assessment Subjects who do not meet the above conditions can be included in the study, however, will participate in the FST under observation only (no glycemic challenges).

Exclusion Criteria

Unable to consent due to a mental or intellectual disability.

Has a history of 1 or more episodes of severe hypoglycemia during the 6 months prior to screening visit.

Has had a hypoglycemic seizure within the past 6 months prior to screening visit.

Has had hypoglycemia resulting in loss of consciousness within the past 6 months prior to enrollment.

Has a history of 1 or more episodes of DKA in the last 6 months prior to screening visit.

T2D: Has had hyperglycemic hyperosmolar syndrome (HHS) in the last 6 months prior to screening visit.

Has a history of a seizure disorder.

Has a central nervous system or cardiac disorder resulting in syncope.

Will not tolerate tape adhesive in the area of sensor placement as assessed by a qualified individual.

Has any unresolved adverse skin condition in the area of sensor placement (e.g., psoriasis, dermatitis herpetiformis, rash, Staphylococcus infection).

Currently pregnant or planning to become pregnant during the time period of study participation

A negative pregnancy test will be required for all females of child-bearing potential at time of screening

For sexually active females of child-bearing potential the investigator will use discretion to determine if the form of contraception that is being used is reliable

Has diagnosis of adrenal insufficiency.

Is using hydroxyurea at time of screening or plans to use it during the study.

Is participating in another pharmaceutical or device trial within 2 weeks of enrollment or anticipates participation in another trial during the course of the study. (Please note participation in an observational study is acceptable.)

Has a planned procedure involving the use of a Magnetic Resonance Imaging (MRI), diathermy devices, or other devices that generate strong magnetic fields (e.g., x-ray, CT scan, or other types of radiation) during the study wear period.

Has elective surgery planned that requires general anesthesia during the course of the study.

T2D: Is using insulin secretagogue.

Is, at the discretion of the investigator, abusing drugs or alcohol

Age 7-80 years: has a hematocrit (Hct) more than 10% below the lower limit of normal reference range (please note that prior blood draw from routine care may be used as long as the prior blood draw was done within 3 months prior to screening and report of lab placed with subject source documents).

Has had any of the following cardiovascular events within 1 year of screening: myocardial infarction, unstable angina, coronary artery bypass surgery, coronary artery stenting, transient ischemic attack, cerebrovascular accident, angina, congestive heart failure, or ventricular rhythm disturbances.

Has had any of the following cardiovascular events more than 1 year prior to screening: myocardial infarction, unstable angina, coronary artery bypass surgery, coronary artery stenting, transient ischemic attack, cerebrovascular accident, angina, congestive heart failure, or ventricular rhythm disturbances. However, subject may participate at the discretion of the investigator and with clearance from the cardiologist.

Has any other disease or condition that may preclude the patient from participating in the study, per investigator judgment.

Is a member of the research staff involved with the study.

Is a sponsor employee or their immediate family member (excluding adult children and/or adult siblings).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chula Vista?

Yes, this clinical trial (NCT07864168) has an active research site in Chula Vista, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Type 1 Diabetes Treatment Options in Chula Vista, CA

If you're searching for type 1 diabetes treatment options in Chula Vista, CA, this clinical trial (NCT07864168) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chula Vista research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all type 1 diabetes clinical trials near you to find additional studies recruiting in your area.

Type 1 Diabetes Clinical Trial in Chula Vista, CA

Expert Care in Chula Vista

IRB Approved

No-Cost Care

Apply for This Chula Vista Location

Why Participate?

Simple Process

About This Type 1 Diabetes Study in Chula Vista